Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How to concentrate nanoparticles and avoid aggregation?

C Vauthier1, B Cabane, D Labarre

  • 1CNRS UMR 8612, Univ Paris-Sud, 92296 Chatenay-Malabry, France. christine.vauthier@u-psud.fr <christine.vauthier@u-psud.fr>

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V
|April 9, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survey of Trichogramma (Hymenoptera: Trichogrammatidae) Natural Populations in Quebec Cranberry Bogs and Identification Using rDNA ITS-2 Sequence Analysis.

Journal of economic entomology·2022
Same author

Defining Endocytic Pathways of Fucoidan-Coated PIBCA Nanoparticles from the Design of their Surface Architecture.

Pharmaceutical research·2022
Same author

Evaluation of zeta potential of nanomaterials by electrophoretic light scattering: Fast field reversal versus Slow field reversal modes.

Talanta·2019
Same author

Characterization of nanomedicines' surface coverage using molecular probes and capillary electrophoresis.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2018
Same author

Towards quality assessed characterization of nanomaterial: Transfer of validated protocols for size measurement by dynamic light scattering and evaluation of zeta potential by electrophoretic light scattering.

International journal of pharmaceutics·2017
Same author

Size of monodispersed nanomaterials evaluated by dynamic light scattering: Protocol validated for measurements of 60 and 203nm diameter nanomaterials is now extended to 100 and 400nm.

International journal of pharmaceutics·2016
Same journal

Does magnesium permeate the skin? An ex vivo investigation of magnesium ion delivery through intact and barrier-disrupted skin.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
Same journal

Surface engineering of graphene as a novel nano-carrier for doxorubicin using sugar-based deep eutectic systems.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
Same journal

Buprenorphine long acting injectables: clinical needs, pharmacodynamic and pharmacokinetic basis, and design challenges for solid preformed implants.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
Same journal

Design rules for externally triggered drug uncaging under optical and radiolytic regimes.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
Same journal

Systematic evaluation of cryopreservation parameters for natural killer cells in clinically relevant cyclic olefin polymer vials.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
Same journal

Erratum to "'Site-specific enrichment of highly sialylated N-glycans in an erythropoietin-hybrid Fc fusion protein" [Eur. J. Pharm. Biopharm. 226 (2026) 115147].

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
See all related articles

A novel dialysis method concentrates nanoparticle suspensions for drug delivery without aggregation. This technique enhances drug carrier concentration, overcoming limitations in pharmaceutical applications and preserving nanoparticle integrity.

Area of Science:

  • Pharmaceutical Nanotechnology
  • Drug Delivery Systems
  • Biomaterials Science

Background:

  • Pharmaceutical nanoparticle suspensions often have low drug carrier content, limiting therapeutic efficacy.
  • High administration volumes are required to achieve therapeutic drug concentrations, exceeding acceptable limits.
  • Conventional concentration methods like centrifugation and lyophilization lead to undesirable aggregate formation.

Purpose of the Study:

  • To develop a simple and effective method for concentrating nanoparticle suspensions.
  • To avoid aggregate formation during the concentration process.
  • To preserve the original characteristics of nanoparticles in concentrated dispersions.

Main Methods:

  • A simple dialysis method against a polymer solution was employed.

Related Experiment Videos

  • Osmotic stress was induced, causing water displacement from the nanoparticle suspension.
  • Various types of nanoparticle suspensions were tested under near equilibrium conditions.

    • Main Results:

    • Concentration factors of up to 50 were achieved within hours at room temperature.
    • The method successfully increased nanoparticle suspension concentration without forming aggregates.
    • The original characteristics of the nanoparticles were fully preserved in the concentrated dispersion.

    Conclusions:

    • Dialysis against a polymer solution is a viable method for concentrating pharmaceutical nanoparticle suspensions.
    • This technique overcomes limitations associated with low drug carrier content and aggregation.
    • The method offers a controlled, reproducible, and efficient way to prepare concentrated nanoparticle dispersions for drug targeting.